Facebook Linkedin Youtube X-twitter Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
Login
  • Home
  • Membership
    • Membership Request
    • Associate Members
    • Types of memberships
    • General Payment Service via Cliq
  • Activity
    • Lectures and conferences
  • Health Education
  • Scientific materials
  • Gallary
    • Videos
    • Photos
  • About US
  • Contact us
  • English
  • من نحن
    • تاريخ الجمعية
    • هيكل الجمعية
    • ادارة الجمعية
    • تطوع معنا
  • العضوية
    • طلب انتساب
    • الاعضاء المنتسبون
    • Types of memberships in the Society of Cardiologists
  • Home
  • نشاطات
  • مواد علمية
  • Health Education
  • جاليري
    • فيديو
    • صور
  • اتصل بنا
Uncategorized
webadmin June 29, 2025 0

The AHA PREVENT Risk Equations

The AHA PREVENT Risk Equations.
Source
• Study published: JAMA Cardiology, June 25, 2025
• Summary article: Medscape Medical News, June 27, 2025
The AHA PREVENT (Predicting Risk of Cardiovascular Disease Events) equations are newer tools developed by the American Heart Association to better estimate a patient’s risk of future cardiovascular disease (CVD)—including heart attacks, strokes, and heart failure.
They are designed to improve on older calculators like the Pooled Cohort Equations, especially in diverse populations.
Study Overview (Published in JAMA Cardiology, June 2025)
1. Objective
To test how well the AHA PREVENT risk calculator works in real-world patients of different ethnicities—particularly Asian and Hispanic populations.
2. Study Design
• Retrospective cohort of 361,778 adults (aged 30–79) seen at Sutter Health (California) from 2010 to 2023.
• Patients were free of CVD at baseline and had all required labs:
• Non-HDL cholesterol
• Systolic BP
• BMI
• eGFR
• Diabetes and smoking status
• Follow-up: Average of 8.1 years
Key Findings
• 22,648 CVD events occurred during follow-up.
• The PREVENT equations predicted risk more accurately than older models across all ethnicities.
Among Asian groups:
• Best performance in Asian Indian subgroup (C-statistic: 0.85).
• Filipino subgroup slightly lower but still good (C-statistic: 0.79).
• In general, risk was slightly overestimated for some Asian subgroups.
Among Hispanic groups:
• Consistent accuracy (C-statistics: 0.80–0.82).
• Calibration was strong—meaning predicted risk matched observed events.
Clinical Takeaways
• The PREVENT calculator is a reliable tool for estimating CVD risk in diverse populations, especially in Asian and Hispanic patients.
• It can guide more personalized and equitable preventive care—e.g., statin decisions, blood pressure goals.
• It’s better than previous tools for many ethnic groups.
Expert Perspective
This model is an important step forward for populations that were previously underrepresented in CVD prevention guidelines,” said Dr. Nilay Shah, Northwestern University.
https://www.medscape.com/viewarticle/aha-risk-calculator-reveals-unique-cardiovascular-patterns-2025a1000h8c
(Timeline & Key Differences: ASCVD vs PREVENT Risk
Calculators):
1. 2013 – ASCVD (Pooled Cohort Equations)
▪ Released by AHA and ACC
▪ Estimates 10-year risk of heart attack and stroke
▪ Race-based (Black/White only)
▪ Limited to age 40–79
2. 2018–2022 – Criticism Grows
▪ Racial bias, poor accuracy in younger and non-White patients
▪ Excludes heart failure or kidney function
▪ Pressure builds for more inclusive models
3. November 2023 – AHA Launches PREVENT
▪ Developed by AHA only (not ACC)
▪ Race-neutral, broader age range (30–79)
▪ Predicts total CVD, not just ASCVD
▪ Includes eGFR, HbA1c, and social determinants
▪ Offers both 10-year and 30-year risk estimates
4. 2025 – PREVENT Validated in Large Diverse Population
▪ Outperforms ASCVD in Asian and Hispanic groups
▪ Stronger calibration, less risk overestimation
▪ Encouraged by AHA as preferred future model
Try the Calculators Yourself
• ASCVD Calculator (2013):
https://tools.acc.org/ASCVD-Risk-Estimator-Plus
• AHA PREVENT Calculator (2023):
https://cvriskcalculator.heart.org
129 Views
21
Boosting InsightJune 29, 2025
How Common Meds Secretly disrupt(or damage) Your Patients’ Microbiome?July 3, 2025

مقالات ذات صلة

Uncategorized

Advances in Bioresorbable Stents for Treating PAD

webadmin March 22, 2025
Uncategorized

Scientific Summary A new FDA clearance for the Aventus Thrombectomy System was officially published on 

webadmin June 25, 2025

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

احدث المقالات

  • Late-Breaking Trials & Science – TCT 2025 (San Francisco, Oct 25–28)
  • Six Trials of Interest at ESC 2025:
  • Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
  • Management of Hypertension in Primary Care – Key Points
  • You Say NOAC, I Say DOAC: Medicine’s Love of Confusing Jargon

فئات

  • Health Education
  • Previous lectures and conferences
  • Uncategorized

Jordanian Cardiology Society

Jordanian Cardiology Society

Amman-Jordan

00962795001983

Working hours

From Sunday to Thursday

From nine in the morning until four in the afternoon

Important Links

Jordanian Cardiology Society

Research and studies

Medical articles

Login

Privacy Policy

Refund Policy

Cancellation Policy

Delivery Policy

Association Location

Copyright © 2024 Jordanian Cardiologists Association by WebAppRoots. All Rights Reserved.